Video

Who's Defining CMC Requirements?

In this segment of the Bioprocess Online Live event Data-Driven CMC For PD Speed, Regulatory Efficiency, CMC experts Brian Kirk, Ph.D. (Merck, Minerva, Takeda) and Blair McNeill, Ph.D. (Amgen, Bayer, Alkermes, Roivant) discuss what forces and organizations are defining CMC requirements for biologic therapies moving forward.

View the full presentation here.

 

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Entegris, Inc.